Home › Multiple Sclerosis › Connecticut
Multiple Sclerosis clinical trials in Connecticut
6 studies for Multiple Sclerosis are looking for participants at sites in Connecticut.
Cities in Connecticut
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Farmington
- TG Therapeutics Investigational Trial Site, Hartford
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06433752Exploring the Utility of [18F]3F4AP for Demyelination Imaging
- Yale University PET Center, New Haven
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 90 · All sexes · Updated Sep 9, 2026 · NCT06999434Identifying and Characterizing Preclinical MS
- Yale University, North Haven
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT05787795Neurologic Stem Cell Treatment Study
- MD Stem Cells, Westport
Recruiting
Ages 18 and older · All sexes · Updated Jun 26, 2026 · NCT02795052Intestinal Immunity in Neurologic Disease
- Yale MS Clinic, North Haven
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 99 · All sexes · Updated May 27, 2026 · NCT06329453From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.